Tokyo, Oct. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063311) titled 'Constipation:Analysis of Patients with Cardiovascular Disease' on Oct. 16.
Study Type:
Observational
Primary Sponsor:
Institute - EA Pharma Co.,Ltd.
Condition:
Condition - chronic constipation
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the real-world burden of constipation among patients with cardiovascular disease through an internet-based survey, including the prevalence and severity of constipation, its impact on quality of life (QOL) and work productivity and activity impairment (WPAI), and current treatment patterns.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients aged 18 years with cardiovascular disease who were registered with the survey panel of Cross Marketing Inc. and provided informed consent to participate in this survey.
Key exclusion criteria - Patients aged <18 years
Target Size - 2500
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 09 Month 30 Day
Date of IRB - 2026 Year 10 Month 15 Day
Anticipated trial start date - 2026 Year 10 Month 16 Day
Last follow-up date - 2026 Year 11 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072407
Disclaimer: Curated by HT Syndication.
